Curetis Announces Participation in Several Investor and Industry Conferences

(PresseBox) ( Amsterdam, the Netherlands and Holzgerlingen, Germany, )
Curetis N.V. (the "Company" and, together with Curetis AG, "Curetis"), a developer of next-level molecular diagnostic solutions, today announced its participation in several major industry conferences in the first quarter of 2016. The respective investor presentations will be made available on the company's website.

January:

J.P. Morgan 34th Annual Healthcare Conference, January 11-14, 2016, in San Francisco, CA.: attendance of the company's management team and one-on-one meetings

February:

Degroof Petercam's Healthcare Seminar, February 3, 2016, in Brussels, Belgium: management presentation

2016 RBC Capital Markets Healthcare Conference, February 23-24, 2016, in New York City, NY: management presentation

March:

BioCapital Europe, March 9, 2016, in Amsterdam, The Netherlands: management presentation

9th Annual European Life Science CEO Forum & Exhibition, March 15-16, 2016, in Zurich, Switzerland: management presentation

36th International Symposium on Intensive Care and Emergency Medicine (ISICEM), March 15-18, 2016, in Brussels, Belgium: scientific meeting.

Legal Disclaimer

This document constitutes neither an offer to buy nor to subscribe securities and neither this document nor any part of it should form the basis of any investment decision in Curetis.

The information contained in this press release has been carefully prepared. However, Curetis bears and assumes no liability of whatever kind for the correctness and completeness of the information provided herein. Curetis does not assume an obligation of whatever kind to update or correct information contained in this press release whether as a result of new information, future events or for other reasons.

This press release includes statements that are, or may be deemed to be, "forward-looking statements". These forward-looking statements can be identified by the use of forward-looking terminology, including the terms "believes", "estimates", "anticipates", "expects", "intends", "may", "will", or "should", and include statements Curetis makes concerning the intended results of its strategy. By their nature, forward-looking statements involve risks and uncertainties and readers are cautioned that any such forward-looking statements are not guarantees of future performance. Curetis' actual results may differ materially from those predicted by the forward-looking statements. Curetis undertakes no obligation to publicly update or revise forward-looking statements, except as may be required by law.

For further information, please visit www.curetis.com.
The publisher indicated in each case is solely responsible for the press releases above, the event or job offer displayed, and the image and sound material used (see company info when clicking on image/message title or company info right column). As a rule, the publisher is also the author of the press releases and the attached image, sound and information material.
The use of information published here for personal information and editorial processing is generally free of charge. Please clarify any copyright issues with the stated publisher before further use. In the event of publication, please send a specimen copy to service@pressebox.de.